New three-drug combination may be effective for newly diagnosed blood cancer patients: Study

New three-drug combination may be effective for newly diagnosed blood cancer patients: Study

When Having the Blues is a Good Thing: Blueberries & Cancer Prevention

In continuation of my up date on the usefulness of blue berries.

Now researchers from the Department of Nutrition Sciences at the University of Alabama at Birmingham, lead by Laura Newton have come up with another interesting finding about blue berries, i.e., as little as a cup a day can help prevent cell damage linked to cancer.

As per the claim by the researchers, free radicals, atoms that contain an odd number of electrons and are highly reactive, can cause cellular damage, one of the factors in the development of cancer; many believe a diet filled with fruits and vegetables may help reduce the risk. 

Lead researcher says

"Studies suggest that antioxidants may help prevent the free-radical damage associated with cancer"

Researchers add that, Blueberries also are rich in vitamin C, which helps the immune system and can help the body to absorb iron. "Vitamin C also helps to keep blood vessels firm, offering protection from bruising. Blueberry juice and other products may be nutritious but often contain less fiber than the whole fruit, and added sugar or corn syrup may decrease their nutritional value. Consuming fresh, raw blueberries provides the most benefits; the average serving size of raw blueberries is one cup, which contains about 80 calories...

More...

Ivabradine also effective in reducing the risk of diastolic heart failure..

Researchers from the Montreal Heart Institute (MHI) have come up with the new findings about the drug,  ivabradine (see structure). Researchers claim that,  a heart rate reduction medication, is also effective in reducing the risk of diastolic heart failure (left ventricular insufficiency) and cardiac fibrosis.

As per the claim by the researchers Ivabradine, reduces Diastolic Dysfunction and Cardiac Fibrosis. The study was conducted on rabbits given a standard diet, a cholesterol-enriched diet or a cholesterol-enriched diet with ivabradine. Researchers found  that apart from improving the myocardial performance index, ivabradine greatly improved left ventricular diastolic dysfunction in animals receiving a cholesterol-enriched diet. Ivabradine also reduced fibrosis of the heart chambers adds the researchers.

According to Dr. Jean-Claude Tardif, Director of the MHI Research Centre and professor of medicine at the Universit- de Montr-al, 

"The effectiveness of ivabradine in treating angina pectoris is now well known. However, few treatments are available to patients with diastolic heart failure. The beneficial effects of ivabradine demonstrated in laboratory suggest that this course of treatment should be further investigated." Clinical studies with subjects are expected to follow..........

http://www.icm-mhi.org/files//pdf/Communique-EN-2011/press_release_Ivabradine.pdf

New anti-cancer agents show promise for treating aggressive breast cancers

New anti-cancer agents show promise for treating aggressive breast cancers

More....

Experimental drug raises 'good' cholesterol, may help control diabetes

Experimental drug raises 'good' cholesterol, may help control diabetes

New breast cancer drug: Promising results of PI3K inhibitor study

 
New breast cancer drug: Promising results of PI3K inhibitor study

Poisonous shrub (Jatropha curcas) extract may act as natural painkiller.....

Poisonous shrub extract may act as natural painkiller

New anti-cancer drugs plus chemo for breast cancer shows promise: Study

 New anti-cancer drugs plus chemo for breast cancer shows promise: Study...

ABT-737

  

                                                        


Docetaxel

FDA approves AstraZeneca's anti-clotting drug Brilinta

 In continuation of my update on  Ticagrelor (Brilinta)......
FDA approves AstraZeneca's anti-clotting drug  Brilinta

FDA approves Lannett's Diethylproprion HCl Tablets ANDA for anti-obesity treatment

FDA approves Lannett's Diethylproprion HCl Tablets ANDA for anti-obesity treatment

Tocotrienol could help reduce stroke damage

In continuation of my update on the benefits of  Vitamin  E

Tocotrienol could help reduce stroke damage

Grape seed polyphenols may help prevent Alzheimer's disease

 In continuation of my update on the usefulness of polyphenols....

 Grape seed polyphenols may help prevent Alzheimer's disease

Grape polyphenols are also called Vineatrols (see structure : vineatrol / trans-resveratrol)

Telaprevir drug shows promise in curing hepatitis C infection

In continuation of my update on Telaprevir...............

Telaprevir drug shows promise in curing hepatitis C infection

Will new drugs (p7 inhibitors) block hepatitis C virus in its tracks?

Will new drugs block hepatitis C virus in its tracks?

FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis

We  know that, Rivaroxaban (structure below BAY 59-7939) is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceuticals. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible....

Now FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery....

More....